Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Related Articles by Review for PubMed (Select 16826486)

1.

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.

J Infect Dis. 2006 Aug 1;194(3):370-6. Epub 2006 Jun 23.

2.

Rotavirus vaccines and vaccination in Latin America.

Linhares AC, Bresee JS.

Rev Panam Salud Publica. 2000 Nov;8(5):305-31. Review.

PMID:
11190969
3.

Review of rotavirus vaccine trials in Finland.

Vesikari T, Joensuu J.

J Infect Dis. 1996 Sep;174 Suppl 1:S81-7. Review.

4.

The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

Clark HF, Offit PA, Plotkin SA, Heaton PM.

Pediatr Infect Dis J. 2006 Jul;25(7):577-83. Review.

PMID:
16804425
5.

Clinical trials of rotavirus vaccines in Europe.

Vesikari T, Giaquinto C, Huppertz HI.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S42-7. Review.

PMID:
16397428
6.

Tetravalent rotavirus vaccine.

Wandstrat TL, Kaplan-Machlis B, Temple ME, Nahata MC.

Ann Pharmacother. 1999 Jul-Aug;33(7-8):833-9. Review.

PMID:
10466913
8.

Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.

Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML, et al.

Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S539-46. Review.

PMID:
2548276
9.

Rotavirus vaccine (RotaTeq).

Keating GM.

Paediatr Drugs. 2006;8(3):197-202; discussion 203-4. Review.

PMID:
16774301
10.

Rotavirus vaccines: entering a new stage of deployment.

Nakagomi O, Cunliffe NA.

Curr Opin Infect Dis. 2007 Oct;20(5):501-7. Review.

PMID:
17762784
11.

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.

Ciarlet M, Schödel F.

Vaccine. 2009 Dec 30;27 Suppl 6:G72-81. doi: 10.1016/j.vaccine.2009.09.107. Review.

PMID:
20006144
12.
13.
14.

Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

Drugs. 2010 Jun 18;70(9):1165-88. doi: 10.2165/11205030-000000000-00000. Review.

PMID:
20518582
15.

Rotavirus vaccine studies in Europe.

Vesikari T.

Acta Paediatr Suppl. 1999 Jan;88(426):9-13. Review.

PMID:
10088905
17.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
18.

Rotavirus vaccines against diarrhoeal disease.

Vesikari T.

Lancet. 1997 Nov 22;350(9090):1538-41. Review.

PMID:
9388411
19.

A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception.

Kapikian AZ, Simonsen L, Vesikari T, Hoshino Y, Morens DM, Chanock RM, La Montagne JR, Murphy BR.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S22-9. Review.

20.

RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.

Chandran A, Santosham M.

Expert Rev Vaccines. 2008 Dec;7(10):1475-80. doi: 10.1586/14760584.7.10.1475. Review.

PMID:
19053204
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk